Cargando…
Inhibition of Receptor-Interacting Protein Kinase 1 with Necrostatin–1s ameliorates disease progression in elastase-induced mouse abdominal aortic aneurysm model
Abdominal aortic aneurysm (AAA) is a common aortic disease with a progressive nature. There is no approved pharmacological treatment to effectively slow aneurysm growth or prevent rupture. Necroptosis is a form of programmed necrosis that is regulated by receptor-interacting protein kinases (RIPs)....
Autores principales: | Wang, Qiwei, Zhou, Ting, Liu, Zhenjie, Ren, Jun, Phan, Noel, Gupta, Kartik, Stewart, Danielle M., Morgan, Stephanie, Assa, Carmel, Kent, K. Craig, Liu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301478/ https://www.ncbi.nlm.nih.gov/pubmed/28186202 http://dx.doi.org/10.1038/srep42159 |
Ejemplares similares
-
Metformin ameliorates established abdominal aortic aneurysms induced by elastase in mice
por: Lu, Hong S., et al.
Publicado: (2023) -
Monocyte Chemoattractant Protein-1 (MCP-1) Regulates Macrophage Cytotoxicity in Abdominal Aortic Aneurysm
por: Wang, Qiwei, et al.
Publicado: (2014) -
Kunming mouse strain is less susceptible to elastase‐induced abdominal aortic aneurysms
por: Liu, Haole, et al.
Publicado: (2021) -
Temporal and Quantitative Analysis of Aortic Immunopathologies in Elastase-Induced Mouse Abdominal Aortic Aneurysms
por: Tian, Kangli, et al.
Publicado: (2021) -
No Effect of Hypercholesterolemia on Elastase-Induced Experimental Abdominal Aortic Aneurysm Progression
por: Ikezoe, Toru, et al.
Publicado: (2021)